Shenzhen Qianhai Taikang Hospital
Official Treatment Cases and Expert Profiles

Sports Medicine is led by Director Lu Wei, a renowned sports medicine specialist and a core member of the Chinese sports medicine discipline. The department has built an internationally advanced shoulder centre and articular cartilage repair centre, and provides specialised services for specific conditions.

1. 1Performed the first arthroscopic anterior cruciate ligament reconstruction in Guangdong Province (double-bundle LARS ligament reconstruction), using an innovative technique with a tolerance of only 1 millimetre to help a 35-year-old badminton player with a torn anterior cruciate ligament and a meniscal tear return to competition sooner.
2. 2Among the first in China to carry out the internationally advanced autologous collagen-induced chondrogenesis (ACIC), giving patients with cartilage damage a more advanced and longer-lasting treatment option.
3. 3Has performed multiple cases of the most difficult procedure in sports medicine and the one with the best return-to-sport outcomes: the arthroscopic LUtarjet procedure (named after Director Lu Wei).

Urology is led by Director Liu Jiumin, former Director of Urology at Guangdong Provincial People's Hospital and a recipient of the "Golden Scalpel Award" for minimally invasive urological surgery in Guangdong Province. He has extensive clinical experience in urinary tumours, urinary stones and congenital malformations, as well as in andrology and kidney transplantation. He is highly skilled in robot-assisted surgery, laparoscopic techniques and minimally invasive treatment of urinary stones. The department continues to perform highly difficult robot-assisted laparoscopic minimally invasive procedures across a wide range of urological fields, including urinary tumours, pelvic tumours and adrenal tumours.

Cardiac Surgery is led by Professor Wang Zhiping, former Director of Cardiac Surgery at The First Affiliated Hospital, Sun Yat-sen University. He is proficient in coronary artery bypass grafting, valvular disease, great vessel disease, congenital heart disease and heart transplantation, and has pioneered several cardiac surgical techniques internationally. The department has performed a series of highly demanding core procedures on an ongoing basis, including valve repair or replacement, correction of congenital heart disease and coronary artery bypass grafting; all patients were transferred out of the intensive care unit (ICU) less than 24 hours after surgery.

1. 1Successfully repaired the "ruptured" heart of a 37-year-old man admitted as an emergency. The patient had a ruptured aortic sinus aneurysm with secondary acute right heart failure and liver and kidney injury; emergency repair of the ruptured aortic sinus aneurysm, tricuspid valvuloplasty and pacemaker implantation were performed, saving his life.
2. 2Performed a combined procedure for a patient from Xinjiang: coronary artery bypass grafting, left ventricular aneurysm resection, thrombectomy and left ventricular reconstruction in one operation, together with endarterectomy of an occluded vessel — one of the most complex operations in cardiac surgery.
3. 3Successfully performed minimally invasive surgery for complex congenital heart disease: Mdm Zhou, aged 50, had congenital heart disease with six atrial septal defects and an associated atrial septal aneurysm, and delay had led to cardiac enlargement, pulmonary hypertension and eventually heart failure. The team performed a minimally invasive cardiopulmonary bypass thoracoscopic repair of the atrial septal defects through a small right intercostal incision that did not damage the sternum, precisely resecting the aneurysm tissue and closing all six atrial septal defects with a patch in one procedure.

1. 1Performed Shenzhen's first transcatheter aortic valve replacement (TAVR) with cerebral protection, a procedure described as "micro-sculpture of the heart". It gave a new lease of life to a 76-year-old patient with severe aortic stenosis and end-stage chronic heart failure, and filled a gap in this technology in Shenzhen.
2. 2Performed Shenzhen's first implantation of a bioresorbable coronary stent (magnesium alloy) under the Hong Kong and Macao medicines and devices scheme for a patient with coronary atherosclerotic heart disease (coronary heart disease); the team has since performed several further cases.
3. 3Performed a highly demanding triple-chamber pacemaker implantation (cardiac resynchronisation therapy defibrillator, CRT-D), bringing hope to a patient with complex heart disease: coronary heart disease, old myocardial infarction, ischaemic cardiomyopathy, cardiac enlargement, complete left bundle branch block and cardiac function class IV.
4. 4Together with Professor Long Ming, a member of Director Liao Xinxue's renowned physician studio in the Department of Cardiovascular Medicine at The First Affiliated Hospital, Sun Yat-sen University, performed percutaneous closure of a patent foramen ovale (Patent Foramen Ovale, PFO), successfully sealing the abnormal channel in the heart and preventing potential thromboembolic events such as stroke at their source.

1. 1Professor Chen Kailin, Director of Thoracic Surgery, together with Professor Wu Jin, Director of Nephrology, successfully performed a mediastinal mass resection without entering the chest cavity for a patient with a mediastinal mass — the first transsternal resection of an ectopic mediastinal parathyroid in Shenzhen. The patient, a 50-year-old man from Hunan, had been receiving dialysis for more than ten years because of kidney failure; from 5 years earlier he had developed generalised itching, bone pain, osteoporosis and resistant hypertension, and was diagnosed with secondary renal hyperparathyroidism. The operation resolved the unexplained hyperparathyroidism that had troubled the patient for years.
2. 2A 79-year-old patient with a malignant tumour in the middle and lower lobes of the right lung showed no obvious tumour shrinkage after 4 cycles of chemotherapy combined with immunotherapy and continued to lose weight. Because of the extensive tumour invasion, severe hilar adhesions (possibly a "frozen hilum") and poor cardiopulmonary function, the hospital performed a single-port thoracoscopic right middle and lower lobectomy with bronchoplasty, intrapericardial management of the pulmonary vessels and mediastinal lymph node dissection — an extremely difficult and high-risk operation. The patient has now recovered and been discharged.

Gastrointestinal Endoscopy is led by Professor Li Chujun, former Head of the Gastrointestinal Endoscopy Department at The Sixth Affiliated Hospital, Sun Yat-sen University, and a holder of the "Lingnan Famous Doctor" and "Yangcheng Good Doctor" honours, with more than 100,000 endoscopic procedures performed. The department has extensive experience in the clinical diagnosis and treatment of digestive system diseases, including diseases of the oesophagus, stomach and intestines as well as hepatobiliary and pancreatic disorders, and in diagnosis and treatment under gastrointestinal endoscopy.

1. 1Successfully performed the "super-minimally invasive", incision-free endoscopic retrograde appendicitis therapy (ERAT), a minimally invasive treatment with rapid recovery.
2. 2Successfully performed minimally invasive endoscopic resection of a large mass (4cm+) in the descending duodenum combined with ERCP (endoscopic retrograde cholangiopancreatography) for a 76-year-old patient from Shunde, Foshan.

Hepatobiliary Surgery is led by Professor Zhou Jie, former Director of the Hepatobiliary and Pancreatic Surgery and Liver Transplantation Centre at Nanfang Hospital of Southern Medical University. He has more than 40 years of frontline clinical experience in hepatobiliary and pancreatic surgery, has successfully diagnosed and treated several hundred cases of benign and malignant hepatobiliary and pancreatic tumours such as liver cancer, cholangiocarcinoma and pancreatic cancer, more than a thousand cases of biliary stone disease (see the note on the original wording at the top of this file), and has personally performed more than 200 liver transplants, 1/3 of which achieved zero blood transfusion. The hospital has already performed a number of major complex liver operations, including liver cancer resection, resection of colorectal cancer liver metastases and resection of hepatic cavernous haemangioma. One patient with a congenital choledochal cyst has followed Director Zhou Jie for 35 years, from Dongguan to Shenzhen, seeking him out again for a highly difficult biliary operation.

1. 1Together with Professor Chen Zhihui of Gastrointestinal Surgery at The First Affiliated Hospital, Sun Yat-sen University, completed a complex, highly difficult laparoscopic operation for Crohn's disease, a type of surgery rarely performed in Shenzhen. The patient had lost weight and passed unformed stools for six months, and was considered to have active Crohn's disease with intestinal stricture and an intestinal fistula. After seeking care at several hospitals without satisfactory response to medication, the patient travelled from Shenzhen to Guangzhou to consult Professor Chen Minhu, and finally followed him to Shenzhen Qianhai Taikang Hospital. After reviewing the patient, Professor Chen Minhu advised active surgical treatment followed by medication, and coordinated experts from The First Affiliated Hospital, Sun Yat-sen University, Director Zhou Jie's general surgery team, Director Chen Qikui's gastroenterology team and the surgical anaesthesia centre to complete a laparoscopic right hemicolectomy with partial ileal resection and repair of a sigmoid fistula.

Respiratory Medicine is led by Professor Zhao Ziwen, former Director of the Department of Respiratory and Critical Care Medicine at Guangzhou First People's Hospital and one of the first "Lingnan Famous Doctors". He has long been engaged in the diagnosis, treatment and research of respiratory diseases, and specialises in the management of critically ill respiratory patients and in interventional respiratory techniques. The department has performed endobronchial valve implantation, stent implantation and other level-IV bronchoscopic interventional procedures that are at the leading edge of the field, all with good outcomes and positive feedback from patients.